Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648763 · ClinicalTrials.gov registry record
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 33
- Enrollment target
NCT02648763: Clinical Trial study, sponsored by Mayo Clinic.
NCT02648763 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02648763 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-01-15 |
| Est. Completion | 2023-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02648763
The ClinicalTrials.gov registry entry for NCT02648763 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02648763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02648763 about?
NCT02648763 is a clinical study titled "Staging Procedures to Diagnose Malignant Pleural Mesothelioma". The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound ...
What is the current status of trial NCT02648763?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2016-01-15. Estimated completion is 2023-04-22.
Who is sponsoring clinical trial NCT02648763?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.